-
1
المؤلفون: Anita Azarkolah, Shahin Akhondzadeh, Mina Tabrizi, Habibeh Yekehtaz, Omid Mirshafiee, Mohammad-Reza Khodaie-Ardakani, M. Moghadam, Farzin Rezaei, Mehdi Farokhnia, Bahman Salehi, Seyed-Mohammad-Hossein Sadeghi, Forod Adinehfar, Fardin Gharibi, Seyed-Mohammad-Reza Hosseini
المصدر: Clinical Neuropharmacology. 36:185-192
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Placebo-controlled study, Placebo, law.invention, Double-Blind Method, Randomized controlled trial, Quality of life, law, Internal medicine, medicine, Humans, Pharmacology (medical), Psychiatry, Adverse effect, Pharmacology, Risperidone, Positive and Negative Syndrome Scale, Free Radical Scavengers, medicine.disease, Acetylcysteine, Treatment Outcome, Schizophrenia, Chronic Disease, Drug Therapy, Combination, Female, Schizophrenic Psychology, Neurology (clinical), Psychology, Antipsychotic Agents, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417e2c27ab19784ef42b5a53d2e41563
https://doi.org/10.1097/wnf.0000000000000001